These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 7465066

  • 21. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K.
    Nihon Rinsho; 1978 Dec 10; 36(12):3884-94. PubMed ID: 372628
    [No Abstract] [Full Text] [Related]

  • 22. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
    Genton E, Gent M, Hirsh J, Harker LA.
    N Engl J Med; 1975 Dec 11; 293(24):1236-40. PubMed ID: 1102983
    [No Abstract] [Full Text] [Related]

  • 23. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
    Bousser MG.
    Ann Med Interne (Paris); 1983 Dec 11; 134(2):79-83. PubMed ID: 6349464
    [No Abstract] [Full Text] [Related]

  • 24. Trials of antiplatelet drugs: some methodological considerations.
    Armitage P.
    Rev Epidemiol Sante Publique; 1979 Sep 18; 27(2):87-90. PubMed ID: 538303
    [No Abstract] [Full Text] [Related]

  • 25. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S.
    Adv Prostaglandin Thromboxane Leukot Res; 1982 Sep 18; 10():173-210. PubMed ID: 6216782
    [No Abstract] [Full Text] [Related]

  • 26. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA, Savenkov MP.
    Ter Arkh; 1988 Sep 18; 60(8):55-9. PubMed ID: 3227479
    [No Abstract] [Full Text] [Related]

  • 27. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG.
    Prog Clin Biol Res; 1982 Sep 18; 89():31-62. PubMed ID: 7051035
    [Abstract] [Full Text] [Related]

  • 28. Clinical aspects of antiplatelet therapy.
    Sherry S.
    Semin Hematol; 1985 Apr 18; 22(2):125-34. PubMed ID: 3890191
    [No Abstract] [Full Text] [Related]

  • 29. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Verstraete M.
    Acta Clin Belg; 1976 Apr 18; 31(4):229-32. PubMed ID: 1087523
    [No Abstract] [Full Text] [Related]

  • 30. [Indications and uncertainties of antiaggregating agents].
    Verstraete M.
    Rev Prat; 1977 Dec 11; 27(57):3999-4005. PubMed ID: 345400
    [No Abstract] [Full Text] [Related]

  • 31. [The platelet inhibitor problem].
    Straub PW.
    Schweiz Med Wochenschr; 1981 Apr 04; 111(14):478-82. PubMed ID: 7015489
    [Abstract] [Full Text] [Related]

  • 32. [Antiplatelet drugs (author's transl)].
    Dechavanne M, Follea G, Trzeciak MC.
    Anesth Analg (Paris); 1979 Apr 04; 36(7-8):283-7. PubMed ID: 525834
    [Abstract] [Full Text] [Related]

  • 33. Platelet aggregation and atherosclerosis.
    Valladares BK, Lemberg L.
    Heart Lung; 1986 Mar 04; 15(2):211-4. PubMed ID: 3633253
    [Abstract] [Full Text] [Related]

  • 34. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
    Avellone G, Mandalà V, Novo S, Pinto A, Riolo FP, Davì G, Raneli G.
    Boll Soc Ital Cardiol; 1981 Mar 04; 26(8):697-712. PubMed ID: 6289854
    [No Abstract] [Full Text] [Related]

  • 35. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec 04; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 36. Treating thromboembolic disease.
    Deykin D, Gurewich V, Harker L, Hirsch J.
    Geriatrics; 1977 Oct 04; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract] [Full Text] [Related]

  • 37. [Platelets and coronary artery disease (CAD) (author's transl)].
    Reimers HJ, Misera R, Schneider W, Loogen F.
    Z Kardiol; 1980 Dec 04; 69(12):799-814. PubMed ID: 7025482
    [Abstract] [Full Text] [Related]

  • 38. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar 21; 22(6):25-6. PubMed ID: 7360108
    [No Abstract] [Full Text] [Related]

  • 39. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG.
    J Mal Vasc; 1983 Mar 21; 8(1):17-22. PubMed ID: 6341494
    [Abstract] [Full Text] [Related]

  • 40. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D.
    Ir Med J; 1983 Feb 21; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.